Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009687751> ?p ?o ?g. }
- W2009687751 endingPage "11" @default.
- W2009687751 startingPage "I" @default.
- W2009687751 abstract "Hypertension is one of the three major risk factors for cardiovascular disease, but levels of blood pressure are by themselves poor predictors of cardiovascular risk. Among subjects with hypertension, a number of phenotypic characteristics are capable of predicting cardiovascular events, but in turn these variables are only weakly related to levels of blood pressure, and may indeed be found in the normotensive as well as the hypertensive population. Among the most powerful predictors of cardiovascular risk are left ventricular hypertrophy (LVH) and microalbuminuria, which may in part represent end-organ damage from elevated blood pressure, but which may also result from the consequence of a common antecedent to that of hypertension. Another common finding in hypertensive subjects is that of insulin resistance, where euglycemia is maintained only at the expense of elevated concentrations of insulin. Several studies, both in diabetic and in nondiabetic subjects, have shown an association between insulin resistance and cardiovascular risk, although it is as yet unclear whether this is independent of the obesity and dyslipidemia associated with insulin resistance. The renin-angiotensin system has been implicated in the etiology of both microalbuminuria and LVH. In insulin-dependent diabetic subjects with microalbuminuria, angiotensin-converting enzyme (ACE) inhibitors have been shown to retard progression to proteinuria and to lower albumin excretion to a greater degree than can be explained by the reduction of blood pressure alone; the same is true in studies of left ventricular mass regression in hypertensive subjects. The relationship between the renin-angiotensin system and insulin resistance is less clear, but ACE inhibitors appear to produce a reduction in insulin resistance, particularly in the non-fasting state. ACE inhibitors may achieve these effects via restoration of endothelial function. The ultimate test of the benefit of any antihypertensive agent is the demonstration of reductions in stroke and in cardiovascular events in large randomized, controlled studies. In the absence of such studies, the potential advantages of newer agents must be set against the proven efficacy of thiazides and beta blockers in providing around 50% reversibility of coronary heart disease risk and virtually 100% reversibility in stroke risk. To attempt to predict the likely efficacy of new agents, the effects of these drugs on a series of surrogate end points must be used. The observations of benefit from ACE inhibitors in terms of left ventricular mass regression and reductions in insulin resistance and in microalbuminuria might predict benefit in reducing major end points. It must be remembered, however, that risk markers such as microalbuminuria and insulin resistance may not represent mechanisms of damage, and thus reversibility of these variables may not necessarily produce better outcomes than can be achieved with older drugs. It is only with end point studies that such questions can be answered." @default.
- W2009687751 created "2016-06-24" @default.
- W2009687751 creator A5024973108 @default.
- W2009687751 date "1995-04-01" @default.
- W2009687751 modified "2023-09-27" @default.
- W2009687751 title "Effects of ACE inhibition on cardiovascular risk factors, insulin resistance, and microalbuminuria" @default.
- W2009687751 cites W1519050139 @default.
- W2009687751 cites W1580515970 @default.
- W2009687751 cites W1769893219 @default.
- W2009687751 cites W1964206499 @default.
- W2009687751 cites W1964275314 @default.
- W2009687751 cites W1972273556 @default.
- W2009687751 cites W1976347558 @default.
- W2009687751 cites W1980410004 @default.
- W2009687751 cites W1981496033 @default.
- W2009687751 cites W1986259394 @default.
- W2009687751 cites W1990246781 @default.
- W2009687751 cites W1992116875 @default.
- W2009687751 cites W1992890029 @default.
- W2009687751 cites W2000379309 @default.
- W2009687751 cites W2004994041 @default.
- W2009687751 cites W2006681515 @default.
- W2009687751 cites W2011277038 @default.
- W2009687751 cites W2013987899 @default.
- W2009687751 cites W2019659743 @default.
- W2009687751 cites W2019823382 @default.
- W2009687751 cites W2025143124 @default.
- W2009687751 cites W2025145003 @default.
- W2009687751 cites W2025439636 @default.
- W2009687751 cites W2027710912 @default.
- W2009687751 cites W2036266922 @default.
- W2009687751 cites W2037417530 @default.
- W2009687751 cites W2042711004 @default.
- W2009687751 cites W2043372493 @default.
- W2009687751 cites W2043623132 @default.
- W2009687751 cites W2046809996 @default.
- W2009687751 cites W2053248115 @default.
- W2009687751 cites W2054790972 @default.
- W2009687751 cites W2058599631 @default.
- W2009687751 cites W2068501383 @default.
- W2009687751 cites W2070252369 @default.
- W2009687751 cites W2075454034 @default.
- W2009687751 cites W2075765797 @default.
- W2009687751 cites W2085507845 @default.
- W2009687751 cites W2091066652 @default.
- W2009687751 cites W2093977794 @default.
- W2009687751 cites W2094843452 @default.
- W2009687751 cites W2096773810 @default.
- W2009687751 cites W2096810815 @default.
- W2009687751 cites W2107165439 @default.
- W2009687751 cites W2111038792 @default.
- W2009687751 cites W2121541303 @default.
- W2009687751 cites W2121960810 @default.
- W2009687751 cites W2136898798 @default.
- W2009687751 cites W2139480984 @default.
- W2009687751 cites W2141230518 @default.
- W2009687751 cites W2141659719 @default.
- W2009687751 cites W2142961055 @default.
- W2009687751 cites W2143029889 @default.
- W2009687751 cites W2144712184 @default.
- W2009687751 cites W2159844688 @default.
- W2009687751 cites W2167469946 @default.
- W2009687751 cites W2167550733 @default.
- W2009687751 cites W2319850088 @default.
- W2009687751 cites W2324579467 @default.
- W2009687751 cites W2334499091 @default.
- W2009687751 cites W2338539226 @default.
- W2009687751 cites W2409844336 @default.
- W2009687751 cites W2414811446 @default.
- W2009687751 cites W2415542308 @default.
- W2009687751 cites W2615684303 @default.
- W2009687751 cites W4238073776 @default.
- W2009687751 cites W4247938048 @default.
- W2009687751 cites W4323238053 @default.
- W2009687751 doi "https://doi.org/10.1002/clc.4960181403" @default.
- W2009687751 hasPublicationYear "1995" @default.
- W2009687751 type Work @default.
- W2009687751 sameAs 2009687751 @default.
- W2009687751 citedByCount "0" @default.
- W2009687751 crossrefType "journal-article" @default.
- W2009687751 hasAuthorship W2009687751A5024973108 @default.
- W2009687751 hasConcept C126322002 @default.
- W2009687751 hasConcept C134018914 @default.
- W2009687751 hasConcept C164705383 @default.
- W2009687751 hasConcept C2776002628 @default.
- W2009687751 hasConcept C2777391703 @default.
- W2009687751 hasConcept C2778096610 @default.
- W2009687751 hasConcept C2779306644 @default.
- W2009687751 hasConcept C2779561371 @default.
- W2009687751 hasConcept C2780091579 @default.
- W2009687751 hasConcept C2781203188 @default.
- W2009687751 hasConcept C555293320 @default.
- W2009687751 hasConcept C71924100 @default.
- W2009687751 hasConcept C84393581 @default.
- W2009687751 hasConceptScore W2009687751C126322002 @default.
- W2009687751 hasConceptScore W2009687751C134018914 @default.
- W2009687751 hasConceptScore W2009687751C164705383 @default.
- W2009687751 hasConceptScore W2009687751C2776002628 @default.